Human Genome Sciences (HGS) has rejected $2.6bn (£1.6bn) takeover bid offered by GlaxoSmithKline (GSK). GSK offered $13 per share, which is 81% premium to HGS closing price on 18 April 2012, of $7.17 per share. HGS has partnered ...
Tags: HGS, GSK, GlaxoSmithKline
Stiefel, a GSK company, has acquired the development and commercialization rights to Welichem Biotech (WBI) anti-inflammatory agent, WBI-1001. The acquisition follows the previously announced asset purchase agreement. WBI-1001 ...
Tags: acquisition, clinical drugs, Stiefel
GlaxoSmithKline (GSK) has announced an agreement with Aspen Global to divest majority of Classic Brands, including 25 non-promoted and genericised products in Australia for approximately £172m in cash. The divested brands include ...
Tags: Valtrex, Lamictal, Timentin, Amoxil, branded and generic pharmaceuticals
Liquidia Technologies has initiated multi-year product development collaboration with GlaxoSmithKline (GSK). Under the collaboration, GSK acquired exclusive rights to research and develop certain vaccine and inhaled product candidates ...
KineMed has entered into a multi-year R&D collaboration GlaxoSmithKline (GSK) to develop kinetic biomarkers. The collaboration will apply KineMed's biomarker discovery platform in therapeutic areas of interest to GSK. KineMed president ...
Tags: kinetic biomarkers, GlaxoSmithKline, KineMed's technology
GlaxoSmithKline (GSK) has entered into a drug discovery alliance with Yale to design a potential new class of medicines that degrade disease-causing proteins. Under the collaboration, GSK integrates its expertise in medicinal chemistry ...
Tags: Yale University, Drug Discovery Alliance, protein-degrading drug
GlaxoSmithKline (GSK) and Chiromics have partnered to discover classes of small molecules against biological targets. The collaboration will leverage Chiromics' compound collections of accessible complexity, Chalis, hit recognition ...
Tags: biological targets, classes of Small Molecules, drug discovery
GlaxoSmithKline's (GSK) Promacta has won FDA approval as thrombocytopenia therapy in chronic hepatitis C patients. Promacta, brand name of eltrombopag in the US, will enable thrombocytopenia patients suffering from chronic hepatitis C ...
Tags: FDA approval, thrombocytopenia therapy, chronic hepatitis C
An IT recruitment expert has criticised government pay thresholds for overseas IT workers in the UK, claiming it groups vastly different jobs together and sets salaries too low, presuming an IT director in the UK can earn as little as ...
Tags: IT workers, MAC, IT professionals, low-cost IT staff
Aquafresh Ultimate,the new''Whole Tooth Protection''flagship brand for GlaxoSmithKline(GSK),is the result of a close collaboration between GSK in-house PacXperience&Consumer Healthcare Futures and strategic brand innovation&design ...
Tags: Collaborate, GSK, collaboration
GlaxoSmithKline (GSK) has signed a definitive agreement to acquire Human Genome Sciences (HGS) for $14.25 per share in cash. The transaction values HGS at approximately $3.6bn on an equity basis, or approximately $3bn net of cash and ...
Tags: GSK, Human Genome Sciences, HGS
GlaxoSmithKline (GSK) and Theravance have announced the regulatory submissions for furoate FF/vilanterol VI (FF/VI) to treat chronic obstructive pulmonary disease (COPD) in the US and Europe. The companies also announced regulatory ...
MARKET OVERVIEW The penetration of CNC machine tools has kept rising since 2002 and reached 29.9% in China in 2011. At present, economical CNC systems are the mainstream products in the Chinese CNC system market, while mid to high-end CNC ...
Tags: market view, CNC System
GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...
Tags: antidepressant, criminal fine, civil claim, health care fraud
The penetration of CNC machine tools has kept rising since 2002 and reached 29.9% in China in 2011. At present, economical CNC systems are the mainstream products in the Chinese CNC system market, while mid to high-end CNC systems occupy a ...
Tags: News Update, Industry Trends, CNC